Table 1 Participant characteristics.

From: Towards prognostic functional brain biomarkers for cervical myelopathy: A resting-state fMRI study

Variable

CM

HC

Participants (n)

28

28

Sex (m/f)

14/14

14/14

Age, years

66.5 ± 10.9 (44–79)

66.5 ± 11.0 (43–79)

Handedness (right/left)

26/2

26/2

Medication

NSAIDs

2

0

Pregabalin

3

0

Tramadol/acetaminophen

1

0

Sedative-hypnotics

7

0

Change in the medication

1 (Stop of pregabalin)

NA

Disease duration (month)

36.4 ± 55.1 (3–246)

NA

  1. CM, cervical myelopathy; HC, healthy control; m, male; f, female; NSAIDs, nonsteroidal anti-inflammatory agents; NA, not applicable.
  2. Data are presented as mean ± SD (range) for continuous variables.